SC 13G

RIGEL PHARMACEUTICALS, INC.

Company: RIGEL PHARMACEUTICALS INC
Filed: December 26, 2007
Accession Number: 0000902664-07-003625

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →

View Document ↗ View on SEC.gov ↗